Medical News

RSS

Research highlights value of serological testing for Coeliac disease in anyone with symptoms

Coeliac disease is one of the most common life-long conditions in Europe, yet many people remain undiagnosed and lengthy diagnostic delays may be putting lives at risk. Today, doctors are being urged to consider testing for Coeliac disease in anyone showing signs and symptoms of the condition and to consider screening everyone in high-risk groups.

25 Apr 2015

Loyola's study on simulated stroke earns prestigious 2015 Safety and Quality Award

A study performed by Loyola University Medical Center resident neurologists has won a prestigious 2015 Safety and Quality Award from the American Academy of Neurology.

25 Apr 2015

Loyola study reports significant increase in major depression during recent Great Recession

The recent Great Recession was accompanied by a significant and sustained increase in major depression in U.S. adults, according to a Loyola study published in the Journal of Clinical Psychiatry.

25 Apr 2015

Toyohashi Tech researchers develop novel cell-manipulation tool to trap, release single cells in microwells

Functional analysis of a cell, which is the fundamental unit of life, is important for gaining new insights into medical and pharmaceutical fields. For efficiently studying cell functions, it is essential to reconstruct cellular microenvironments by parallel manipulation of single cells. Various cell manipulation techniques including fluidic, optical, and electrical techniques have been developed.

25 Apr 2015

Study identifies BLU-554 as potential treatment option for HCC patients

Findings were presented today at The International Liver CongressTM 2015 on a novel therapeutic candidate for a genomically defined subset of hepatocellular carcinoma (HCC) patients with an aberrant fibroblast growth factor receptor 4 (FGFR4) pathway.

25 Apr 2015

Study shows NASH linked to 50% higher death rates compared with NAFLD

Results from a large population-based cohort of almost a million people in the UK found that the chances of dying from non-alcoholic steatohepatitis (NASH), over a 14-year period, was approximately 50% higher than for those with non-alcoholic fatty liver disease (NAFLD).

25 Apr 2015

Study: Cancer rates in HCV patients significantly increase compared to non-HCV cohort

Results announced today at The International Liver Congress 2015 show that cancer rates in patients with the hepatitis C virus (HCV) were significantly increased compared to the non-HCV cohort. The researchers suggest an extrahepatic manifestation of HCV may be an increased risk of cancer.

25 Apr 2015

Actavis reports positive results from phase 3 study of single-dose DALVANCE for treatment of ABSSSI

Actavis plc today announced positive top-line results for study DUR001-303, a phase 3 study comparing a single 1500 mg dose of DALVANCE with the same total dose given as two-doses one week apart, for the treatment of acute bacterial skin and skin structure infections (ABSSSI) caused by susceptible Gram-positive bacteria, including methicillin resistant Staphylococcus aureus (MRSA).

25 Apr 2015

Positive CHMP opinion recommends RELISTOR for treatment of opioid-induced constipation

Valeant Pharmaceuticals International, Inc. and Progenics Pharmaceuticals, Inc. today announced that the Committee for Medicinal Products for Human Use of the European Medicines Agency has adopted a positive opinion recommending a new indication for RELISTOR (methylnaltrexone bromide) Subcutaneous Injection for the treatment of opioid-induced constipation (OIC) when response to laxative therapy has not been sufficient in adult patients, aged 18 years and older.

25 Apr 2015

Natera, LifeLabs sign new agreement for non-invasive prenatal testing in Canada

Natera, Inc., a global leader in non-invasive genetic testing, and LifeLabs Medical Laboratory Services today announced a new agreement that gives LifeLabs the rights to perform non-invasive prenatal testing (NIPT) in Canada using Natera technology.

From Natera 25 Apr 2015

Lilly receives fourth FDA approval for CYRAMZA (ramucirumab)

Eli Lilly and Company has received its fourth U.S. Food and Drug Administration approval for CYRAMZA (ramucirumab). CYRAMZA (ramucirumab injection 10 mg/mL solution) is now also indicated in combination with FOLFIRI (irinotecan, folinic acid, and 5-fluorouracil) chemotherapy for the treatment of patients with metastatic colorectal cancer (mCRC) with disease progression on or after prior therapy with bevacizumab, oxaliplatin, and a fluoropyrimidine.

25 Apr 2015

Xstrahl introduces Phtotoelectric therapy to the European market at ESTRO 2015

Utilising trusted and clinically proven low energy photons, in a dedicated treatment system. Photoelectric Therapy provides a pain free, non-surgical alternative for the treatment of non-melanoma skin cancer, especially those found in sensitive areas of the head and neck...

24 Apr 2015

Porvair Previews New Microplate Products at ACHEMA

Visitors to ACHEMA 2015 have been invited by Porvair Sciences to Stand F44 in Halle 4.2 to see their expansive range of application optimised microplates and microplate equipment...

From Porvair Sciences Limited 24 Apr 2015

Asthma breakthrough: potential cause and corrective treatment are identified

A paper published yesterday in Science Translational Medicine reports that the root cause of asthma has been found and a potential treatment to reverse all symptoms has been proposed...

24 Apr 2015

Children's Memorial Hermann Hospital attains Baby-Friendly designation

Baby-Friendly USA announced this week that Children's Memorial Hermann Hospital has received prestigious international recognition as a Baby-Friendly designated birth facility. A hospital can only be deemed "Baby-Friendly" after the completion of a rigorous onsite assessment survey and a final review of the External Review Board.

24 Apr 2015

Lannett amends, increases revolving credit facility from $50 million to $120 million

Lannett Company, Inc. today announced that it has amended and increased its five-year revolving credit facility to $120 million from $50 million. The amended facility includes an accordion feature that will allow the company to increase borrowings by a total of up to an additional $30.0 million, subject to securing additional commitments from existing lenders or new lending institutions.

24 Apr 2015

Dry eye strikes most often in spring

New ophthalmology research from the University of Miami shows that dry eye - the little understood culprit behind red, watery, gritty feeling eyes - strikes most often in spring, just as airborne allergens are surging.

24 Apr 2015

Ultrasound settings can change beat frequency of cardiac cells

Ultrasound—the technology used for sonograms and examining the heart—can increase the rate at which heart cells beat, researchers from Drexel University report.

24 Apr 2015

Study: Long-term exposure to air pollution can damage brain structures, impair cognitive function

Air pollution, even at moderate levels, has long been recognized as a factor in raising the risk of stroke. A new study led by scientists from Beth Israel Deaconess Medical Center and Boston University School of Medicine suggests that long-term exposure can cause damage to brain structures and impair cognitive function in middle-aged and older adults.

24 Apr 2015

Children riding school buses with cleaner fuels and technologies experience better lung development

Use of clean fuels and updated pollution control measures in the school buses 25 million children ride every day could result in 14 million fewer absences from school a year, based on a study by the University of Michigan and the University of Washington.

24 Apr 2015

Medical News

Research highlights value of serological testing for Coeliac disease in anyone with symptoms

Loyola's study on simulated stroke earns prestigious 2015 Safety and Quality Award

Loyola study reports significant increase in major depression during recent Great Recession

Toyohashi Tech researchers develop novel cell-manipulation tool to trap, release single cells in microwells

Study identifies BLU-554 as potential treatment option for HCC patients

Study shows NASH linked to 50% higher death rates compared with NAFLD

Study: Cancer rates in HCV patients significantly increase compared to non-HCV cohort

Actavis reports positive results from phase 3 study of single-dose DALVANCE for treatment of ABSSSI

Positive CHMP opinion recommends RELISTOR for treatment of opioid-induced constipation

Natera, LifeLabs sign new agreement for non-invasive prenatal testing in Canada

Lilly receives fourth FDA approval for CYRAMZA (ramucirumab)

Xstrahl introduces Phtotoelectric therapy to the European market at ESTRO 2015

Porvair Previews New Microplate Products at ACHEMA

Asthma breakthrough: potential cause and corrective treatment are identified

Children's Memorial Hermann Hospital attains Baby-Friendly designation

Lannett amends, increases revolving credit facility from $50 million to $120 million

Dry eye strikes most often in spring

Ultrasound settings can change beat frequency of cardiac cells

Study: Long-term exposure to air pollution can damage brain structures, impair cognitive function

Children riding school buses with cleaner fuels and technologies experience better lung development

How real-time off-gas analysis improves fermentation process control

Advancing Drug Safety Assessment With AI, Predictive Modeling, and Human-Relevant Data

AI-powered analytics and experimental validation

Latest News